… These facts leave no doubt that lung cancer will be a major public health problem for many
… the standard management of lung cancer, explores current and emerging chemotherapeutic …

… lung Cancer (NSCLC) patients in good clinical condition (PS 0–1), Platin-based combination
chemotherapy … increased the chemotherapeutic options for Platin-based chemotherapy and…

… outcomes from standard, first-line chemotherapy for NSCLC … A previous review of phase II
and early-stage lung cancer … covering domains for patients with lung cancer, whereas in the …

… Although the disease is highly sensitive to chemotherapy and radiation, cure is difficult to …
is the accepted standard chemotherapeutic regimen. It is also the accepted standard therapy in …

… combine chemotherapy and targeted therapy in lung cancer … of comparisons of standard
chemotherapy doublet and … of a targeted agent to standard chemotherapy in lung cancer. Trial …

… However, chemotherapy resistance limits our ability to effectively treat advanced lung cancer…
key mechanisms of resistance for commonly used chemotherapeutic agents in lung cancer. …

… In concert with broader applicability of chemotherapy, translational studies have provided …
role of chemotherapy in both early and advanced non-small-cell and small-cell lung cancer. …

… cause of cancer-related mortality with an estimated 1.38 million deaths per annum (1).
Small-cell lung cancer (SCLC) accounts for between 10% to 15% of all lung cancer cases and is …

… , and colon cancer combined. The … cell lung cancer is only four to five months, with a survival
rate at one year of only 10 percent. Chemotherapy for advanced non–small-cell lung cancer …

… Adjuvant chemotherapy (AC) plays now a significant role in the treatment of resected non-small
cell lung cancer (NSCLC) patients and has become standard in clinical practice. It took …